Live Breaking News & Updates on Vivogene Editing Program

Stay updated with breaking news from Vivogene editing program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results

09.08.2022 - Over $300 Million in Capital Added to Balance Sheet, Supporting an Operating Runway into Second Half of 2025 Patient Dosing Underway with Lead Candidate, VERVE-101, for Treatment of Heterozygous Familial Hypercholesterolemia; Regulatory . ....

United States , United Kingdom , New Zealand , John Evans , Jen Robinson , Alexanderg Bo Cumbo , Ashlea Kosikowski , Allison Dorval , Sekar Kathiresan , Eisai Corporation Of North America , Janssen Pharmaceuticals Inc , Vertex Pharmaceuticals Incorporated , Verve Therapeutics Inc , Research Development Rd Expenses , European Society Of Cardiology , Sarepta Therapeutics Inc , Vertex Pharmaceuticals , Lexicon Pharmaceuticals , Gilead Sciences , Eisai Inc , Aavantibio Inc , Research Collaboration , Exchange Commission , Company Evolution , Business Development , Vivogene Editing Program For Liver Disease ,